Metagenomics Specialists analyze genetic material from microbial communities in various environments, including the human gut, soil, oceans, and extreme habitats. Their work provides insights into microbial diversity, function, and interactions without the need for traditional culturing methods.
Using advanced DNA sequencing technologies and bioinformatics, these specialists identify microbial species, study gene functions, and explore their roles in health, agriculture, and biotechnology. In human health, metagenomics helps understand the gut microbiome’s impact on digestion, immunity, and disease, contributing to the development of microbiome-based therapies. Beyond healthcare, metagenomics specialists contribute to environmental science by studying microbes involved in nutrient cycling, pollution breakdown, and climate change adaptation. Their research also supports advancements in food safety, drug discovery, and industrial microbiology. They investigate how diet, antibiotics, and lifestyle factors alter microbial diversity, leading to new strategies for restoring gut health. Their findings also contribute to advancements in precision medicine, where treatments are tailored based on an individual's microbiome composition. By leveraging next-generation sequencing (NGS), whole-genome shotgun sequencing, and bioinformatics, metagenomics specialists can identify previously unknown bacterial, viral, fungal, and archaeal species, mapping their genetic blueprints and metabolic functions. In human health and microbiome research, their work is instrumental in uncovering how microbial imbalances contribute to gastrointestinal disorders, metabolic diseases, autoimmune conditions, and even neurological disorders through the gut-brain axis. These insights drive the development of precision probiotics, microbiome-based therapeutics, and personalized nutrition strategies.
Title : Results from a cross-sectional observational study examining irritable bowel syndrome patients six months after finishing their participation in the ViIBS trial
Jacek Piatek, Calisia University, Poland
Title : Gut microbiome as a driver of healthy ageing
Thi Thu Hao Van, RMIT University, Australia
Title : Treating irritable bowel syndrome patients with a balanced multi-strain synbiotic–results from a multi-center, randomized, double-blind, placebo-controlled clinical trial (the ViIBS trial)
Henning Sommermeyer, Calisia University, Poland
Title : Molecular mechanisms underlying the anti-atherogenic actions of probiotics
Dipak P Ramji, Cardiff University, United Kingdom
Title : Global regulatory trends on the use of probiotics and prebiotics in foods and food supplements
David Pineda Ereno, DPE International Consulting, Belgium
Title : Biochemical profile and nutripotential glimpses of Terminalia arjuna bark extract
Suriyavathana Muthukrishnan, Periyar University, India